ALDER BIOPHARMACEUTICALS INC Interest Expense
ALDER BIOPHARMACEUTICALS INC reported Interest Expense of $4.97 million for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-06.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2019-08-06
- ALDER BIOPHARMACEUTICALS INC interest expense for the quarter ending 2019-06-30 was $4.97M, a 6.12% increase year-over-year.
- ALDER BIOPHARMACEUTICALS INC interest expense for the quarter ending 2019-03-31 was $4.84M, a 69.69% increase year-over-year.
- ALDER BIOPHARMACEUTICALS INC interest expense for the quarter ending 2018-12-31 was $4.86M.
- ALDER BIOPHARMACEUTICALS INC interest expense for the quarter ending 2018-09-30 was $4.78M.
- ALDER BIOPHARMACEUTICALS INC interest expense for fiscal 2018 was $17.18M.
- ALDER BIOPHARMACEUTICALS INC interest expense for fiscal 2012 was $88.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2019-06-30 | $4.97M 10-Q · filed 2019-08-06 | $9.81M 10-Q · filed 2019-08-06 | $14.68M derived: sum of 3 quarters · filed 2019-08-06 | $19.46M derived: sum of 4 quarters · filed 2019-08-06 |
| 2019-03-31 | $4.84M 10-Q · filed 2019-05-02 | $9.70M derived: sum of 2 quarters · filed 2019-05-02 | $14.48M derived: sum of 3 quarters · filed 2019-05-02 | $19.17M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-12-31 | $4.86M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $9.65M derived: sum of 2 quarters · filed 2019-02-25 | $14.33M derived: sum of 3 quarters · filed 2019-08-06 | $17.18M 10-K · filed 2019-02-25 |
| 2018-09-30 | $4.78M 10-Q · filed 2018-11-05 | $9.47M derived: sum of 2 quarters · filed 2019-08-06 | $12.32M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $4.69M 10-Q · filed 2019-08-06 | $7.54M 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $2.85M 10-Q · filed 2019-05-02 | |||
| 2012-12-31 | $88.00K 10-K · filed 2015-03-13 |